BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Pancreas
,
Neocentromeres
,
Fenofibrate
,
rs2476601
,
CXCL2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TUSC2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Skeletal muscle psoas
Cerebellum peduncles
Cingulate cortex
Globus pallidus
Pons
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanize…
NEDD4 degrades TUSC2 to promote glioblastoma progression.
Mitochondrial protein Fus1/Tusc2 in premature aging and age-related pathologies: critical roles of c…
The HDAC inhibitor HFY-4A improves TUSC2 transcription to induce immunogenic cell death in breast ca…
Circ-EGFR Functions as an Inhibitory Factor in the Malignant Progression of Glioma by Regulating the…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer
Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-Small…
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progres…
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ